Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank 薬物名（臨床試験情報から抽出） KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Ustekinumab 💬
(Ustekinumab (USAN/INN), Ustekinumab (genetical recombination) (JAN), Ustekinumab (genetical recombination) [Ustekinumab biosimilar 1] (JAN), Ustekinumab (genetical recombination) [Ustekinumab biosimilar 2] (JAN), Ustekinumab (genetical recombination) [Ustekinumab biosimilar 3] (JAN), Ustekinumab-aauz, Ustekinumab-auub, Ustekinumab-ttwe, Ustekinumab-aekn, USTEKINUMAB, USTEKINUMAB-AEKN, USTEKINUMAB-TTWE)		1件: Ustekinumab (Ustekinumab)1件: Ustekinumab3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬16件: 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬